BTIG Maintains Buy on IperionX, Raises Price Target to $55

Iperionx Ltd. Sponsored ADR

Iperionx Ltd. Sponsored ADR

IPX

0.00

BTIG analyst Gregory Lewis maintains IperionX (NASDAQ: IPX) with a Buy and raises the price target from $40 to $55.